Biotechnology is a rapidly growing industry worldwide, and India is no exception. Several Indian biotechnology firms are at the forefront of cutting-edge research and development, striving to enhance human life through scientific advancements.
Biotechnology involves the application of modern science and technology to living organisms. This includes utilizing biotechnological methods to develop innovative products and improve plants, animals, and microorganisms. Indian biotechnology companies are actively engaged in creating new drugs, vaccines, diagnostics, and other medical solutions to combat diseases.
The pharmaceutical sector in India attracts substantial investments, as the country is the largest manufacturer of generic drugs globally. With an increasing number of companies entering the sector, the biotechnology industry in India is experiencing rapid expansion and holds immense potential for future growth.
Below is a list of the top 10 biotechnology companies in India.
Biocon Limited, headquartered in Bangalore, was established in 1978. The company is chaired by Kiran Mazumdar-Shaw, with Siddharth Mittal serving as the Chief Executive Officer and Managing Director.
With a strong focus on research and development, Biocon invests significantly in innovation. In the previous year, the company allocated ₹5,271 crore toward R&D initiatives. Biocon holds over 1,220 patents and is currently developing ALZUMAbTM, a biologic drug for psoriasis, which is also being explored for use in combating the global pandemic.
Biocon manufactures a wide range of pharmaceuticals, including Gliptins, Peptides, Immunosuppressants, Statins, and Oncology medications. Estimated Market Value: ₹49,116 crore.
GlaxoSmithKline Pharmaceuticals Ltd. dominates India's patient-paid vaccine market. The company’s R&D pipeline includes 37 potential new drugs and 15 vaccines.
Some of GSK’s most recognized pharmaceutical brands include Betnovate, Calpol, Augmentin, and Eltroxin. It has also developed well-known vaccines such as Synflorix and Rotarix. Pharmaceuticals contribute 83% of the company’s total sales, while vaccines account for the remaining 17%.
Headquartered in Mumbai, the company is chaired by R. S. Karnad. Estimated Market Value: ₹45,117 crore.
Syngene International focuses on scientific research to enhance human and animal health. The company employs over 4,200 scientists and holds more than 400 patents.
With manufacturing facilities in Bengaluru and Mangaluru, along with R&D centers in Bengaluru and Hyderabad, Syngene serves industries such as pharmaceuticals, biotechnology, nutrition, and specialty chemicals.
Founded in 1993, Syngene is chaired by Kiran Mazumdar-Shaw, with Jonathan Hunt as the CEO. Estimated Market Value: ₹26,421 crore.
Jubilant Life Sciences operates in over 100 countries and is a leading name in India's biotechnology sector. The company specializes in CVF, CNF, anti-infective, and anti-diabetic medications.
Committed to sustainability, Jubilant focuses on minimizing its environmental impact and tracks progress across social, environmental, and economic domains.
Headquartered in Uttar Pradesh, the company is chaired by Shyam S Bhartia. Estimated Market Value: ₹45,117 crore.
Wockhardt Ltd., headquartered in Mumbai, is a pharmaceutical and biotechnology firm founded in 1960. The company generates 76% of its revenue from the U.S. and European markets but is now focusing on expansion in India.
Under the leadership of Chairman Habil Khorakiwala, Wockhardt is poised for significant growth in the Indian biotech industry. Estimated Market Value: ₹6,222 crore.
As part of Sun Pharma’s reorganization, Sun Pharmaceutical Advanced Research Company was established to focus on pharmaceutical research and development. The company emphasizes innovative drug formulations and patient care improvements.
In 2020, Sun Pharma collaborated with the University of Michigan for research and development of new medicines.
Headquartered in Mumbai, the company is chaired by Dilip S. Shanghvi. Estimated Market Value: ₹6,564 crore.
Founded in 1976, Panacea Biotec is a leading pharmaceutical and biotechnology company known for its expertise in vaccine development.
With strong leadership and a dedicated workforce, the company has received recognition, including the Bio Spectrum Product of the Year award for its PacliALL product in 2011.
Headquartered in Punjab, the company is chaired by Sushil Kumar Jain. Estimated Market Value: ₹6,564 crore.
Founded in 1984 by Dr. K Anji Reddy, Dr. Reddy’s Laboratories aims to make medicines affordable. Initially producing Ibuprofen APIs, the company later expanded to formulations and became a major exporter to the U.S., Europe, and Asia.
Some of its well-known products include Omez (Omeprazole), Nise (Nimesulide), and Razo (Rabeprazole). Estimated Market Value: ₹704.45 billion.
Founded in 1966, Serum Institute of India is one of the country’s most reputable biotechnology firms. The company specializes in vaccine development and has created products like DTaP vaccines and Vero cell rabies vaccines.
Under the leadership of Chairman Cyrus S. Poonawalla, Serum Institute is headquartered in Pune. Estimated Market Value: ₹2,251 crore.
Established in 1982 by the National Dairy Development Board (NDDB), Indian Immunologicals has grown into a leading biotechnology company in India.
Headquartered in Hyderabad, the company is chaired by Dr. Amrita Patel and is known for its high-quality services in vaccine development. Estimated Market Value: ₹140 crore.
India ranks among the top 30 biotechnology hubs globally. With continuous investments in research and development, Indian biotechnology firms are making significant contributions to healthcare and pharmaceuticals. These top companies are driving innovation, ensuring India's prominence in the global biotech landscape.
